• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Infliximab for severe colitis associated with nivolumab followed by ipilimumab.

作者信息

Fukumoto Takeshi, Fujiwara Susumu, Tajima Shoko, Tamesada Yukari, Sakaguchi Masanobu, Oka Masahiro, Nishigori Chikako

机构信息

Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.

Division of Dermatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

出版信息

J Dermatol. 2018 Jan;45(1):e1-e2. doi: 10.1111/1346-8138.14034. Epub 2017 Sep 11.

DOI:10.1111/1346-8138.14034
PMID:28891241
Abstract
摘要

相似文献

1
Infliximab for severe colitis associated with nivolumab followed by ipilimumab.英夫利昔单抗用于治疗与纳武单抗随后伊匹单抗相关的严重结肠炎。
J Dermatol. 2018 Jan;45(1):e1-e2. doi: 10.1111/1346-8138.14034. Epub 2017 Sep 11.
2
Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin.平衡检查点：管理与双重检查点抑制剂和高剂量阿司匹林相关的结肠炎
Dig Dis Sci. 2019 Mar;64(3):685-688. doi: 10.1007/s10620-019-05534-5.
3
Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.纳武单抗诱发恶性黑色素瘤患者的结肠炎：一例病例报告及免疫分析
J Dermatol. 2019 Sep;46(9):e339-e341. doi: 10.1111/1346-8138.14857. Epub 2019 Mar 25.
4
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab.免疫检查点抑制剂相关性结肠炎治疗中使用英夫利昔单抗导致的急性肝损伤。
J Immunother Cancer. 2019 Feb 18;7(1):47. doi: 10.1186/s40425-019-0532-1.
5
Efficacy and toxicity of ipilimumab used after nivolumab in patients with melanoma.纳武单抗治疗后使用伊匹木单抗治疗黑色素瘤患者的疗效和毒性
J Dermatol. 2018 Oct;45(10):e287-e289. doi: 10.1111/1346-8138.14325. Epub 2018 Apr 14.
6
Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.一名转移性恶性黑色素瘤患者在使用纳武单抗治疗失败后，因使用伊匹单抗诱发大疱性类天疱疮。
J Dermatol. 2018 Jan;45(1):e21-e22. doi: 10.1111/1346-8138.14043. Epub 2017 Sep 25.
7
Immune-Mediated Colitis due to Concurrent Ipilimumab and Nivolumab Therapy Treated With Infliximab.英夫利昔单抗治疗同时使用伊匹单抗和纳武单抗导致的免疫介导性结肠炎
Am J Ther. 2020 Jul/Aug;27(4):e415-e417. doi: 10.1097/MJT.0000000000001165.
8
Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.一名黑色素瘤患者在接受纳武单抗治疗后使用伊匹单抗治疗时发生1型糖尿病。
J Dermatol. 2018 Oct;45(10):e289-e290. doi: 10.1111/1346-8138.14331. Epub 2018 Apr 18.
9
[Histoseminar on inflammatory bowel diseases (IBD): Case n 04].[炎症性肠病（IBD）组织学研讨会：病例编号04]
Ann Pathol. 2017 Aug;37(4):298-301. doi: 10.1016/j.annpat.2017.06.005. Epub 2017 Jul 19.
10
Infliximab Therapy for Corticosteroid-Resistant Ipilimumab-Induced Colitis.英夫利昔单抗治疗对皮质类固醇耐药的伊匹单抗诱导的结肠炎。
J Gastrointestin Liver Dis. 2015 Sep;24(3):274. doi: 10.15403/jgld.2014.1121.243.bwp.

引用本文的文献

1
Pathological characteristics of inflammatory bowel diseases.炎症性肠病的病理特征
J Med Ultrason (2001). 2025 Apr;52(2):187-196. doi: 10.1007/s10396-025-01520-9. Epub 2025 Mar 1.
2
Immune Checkpoint Inhibitor-Associated Celiac Disease: A Retrospective Analysis and Literature Review.免疫检查点抑制剂相关的乳糜泻：一项回顾性分析及文献综述
Diseases. 2024 Dec 3;12(12):315. doi: 10.3390/diseases12120315.
3
Secondary causes of inflammatory bowel diseases.炎症性肠病的继发原因。
World J Gastroenterol. 2020 Jul 28;26(28):3998-4017. doi: 10.3748/wjg.v26.i28.3998.
4
Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study.免疫检查点抑制剂（程序性死亡-1抑制剂和细胞毒性T淋巴细胞相关蛋白-4抑制剂）的不良反应：一项回顾性研究的结果
J Clin Med Res. 2019 Apr;11(4):225-236. doi: 10.14740/jocmr3750. Epub 2019 Mar 18.